# Bristol-Myers Squibb Company (BMY) — Q3-2014 Earnings Results

**Report date:** 2014-10-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2014

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 2.15%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.45 | N/A | +8.96% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They noted the importance of their product pipeline in driving future growth.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a positive surprise in EPS, which contributed to a 2.15% increase in stock price. The management's focus on their product pipeline and strong performance in key areas suggests a commitment to future growth. However, the lack of revenue data and guidance leaves some uncertainty for investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2014_